Use of Botulinum Toxin in Neurology

被引:0
|
作者
Ehler, Edvard [1 ,2 ]
机构
[1] Univ Pardubice, Fac Hlth Studies, Pardubice 53210, Czech Republic
[2] Pardubicke Krajske Nemocnice As, Pardubice 53203, Czech Republic
关键词
botulinum toxin; neuromuscular transmission; chemodenervation; dystonia; spasticity; UPPER-LIMB SPASTICITY; DOUBLE-BLIND; EFFICACY; PLACEBO; SAFETY; STROKE; ONABOTULINUMTOXINA; MANAGEMENT;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Botulinum toxin is one of the strongest natural toxins. The toxin is produced by anaerobic bacteria Clostridium botulinum. The substance causes a block of acetylcholine release on the neuromuscular endplate with subsequent disruption of impulse transmission on the muscle. At the same time, botulinum toxin causes denervation syndrome of the muscle into which it was administered. There are seven types of botulinum toxin with effects on various proteins in presynaptic ending. In contemporary clinical practice, botulinum toxin has been used for more than 30 years and drugs with botulinum toxin A and B are available. At present, two medicinal products containing botulinum toxin A (Botox and Dysport) and one with botulinum toxin B (NeuroBloc) are available. Botulinum toxin is a highly effective drug used in many clinical conditions associated with increased skeletal muscle activity and increased activity of autonomic system. Botulinum toxin is indicated and reimbursed by insurance companies for cervical dystonia, other dystonias, blepharospasm, hemifacialis spasm, upper limb spasticity after stroke, and upper and lower limb spasticity in cerebral palsy. It also has proven efficacy in chronic headache, sfincter-detrusor dyssynergia of urine bladder, hyperhidrosis, sialorhoea, in gastroenterologic disorders (achalasia, anal fissure), cosmetic indications and in a number of other conditions. Contraindications include pregnancy, lactation, some neuromuscular diseases, haemocoagulation disorders including anticoagulation therapy (INR > 2.8) and inflammatory changes of the skin at the administration site. Adverse events include intensive muscle weakness, pain, hemorrhage into the muscle or subcutaneous tissue, headache as well as flu-like symptoms. Botulinum toxin is injected into muscles or subcutaneous tissue either directly "from hand", guided by EMG signal with a support of hollow monopolar EMG needle electrode, by direct stimulation of the muscle with hollow EMG needle electrode, guided by ultrasonography (position of the needle and the belly of a muscle) or CT.
引用
收藏
页码:7 / 21
页数:15
相关论文
共 50 条
  • [1] An Update on Botulinum Toxin in Neurology
    Chiu, Shannon Y.
    Burns, Matthew R.
    Malaty, Irene A.
    NEUROLOGIC CLINICS, 2021, 39 (01) : 209 - 229
  • [2] The use of Botulinum toxin in clinical neurology
    Vigl, M
    Földy, D
    Neuhauser, J
    Auff, E
    Schnider, P
    PERIODICUM BIOLOGORUM, 2002, 104 (01) : 31 - 37
  • [3] Botulinum toxin in neurology
    Vidailhet, M
    REVUE DE MEDECINE INTERNE, 2005, 26 (07): : 531 - 533
  • [4] Use of botulinum toxin in the neurology clinic
    Lim, Erle C. H.
    Seet, Raymond C. S.
    NATURE REVIEWS NEUROLOGY, 2010, 6 (11) : 624 - 636
  • [5] Botulinum toxin therapy in rehabilitative neurology
    Dressler, D
    Argyrakis, A
    Schonle, PW
    Wochnik, G
    Ruther, E
    NERVENARZT, 1996, 67 (08): : 686 - 694
  • [6] Non-cosmetic use of botulinum toxin in surgical conditions
    Marker, Line
    Toquer, Peter
    Helgstrand, John Thomas
    Helgstrand, Frederik
    SCANDINAVIAN JOURNAL OF SURGERY, 2024, 113 (04) : 324 - 331
  • [7] Applications of botulinum toxin in Neurology
    Garcia-Ruiz, Pedro J.
    MEDICINA CLINICA, 2013, 141 (01): : 33 - 36
  • [8] Botulinum Toxin in Clinical Neurology
    Wissel, J.
    Kempf, F.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2012, 80 (03) : 167 - 178
  • [9] Botulinum toxin treatment in neurology
    Schnider, P
    Wissel, J
    NEUROPSYCHIATRIE, 2000, 14 (04) : 213 - 222
  • [10] OUTCOMES OF AMBULATORY REHABILITATION PROGRAMMES FOLLOWING BOTULINUM TOXIN FOR SPASTICITY IN ADULTS WITH STROKE
    Demetrios, Marina
    Gorelik, Alexandra
    Louie, Julie
    Brand, Caroline
    Baguley, Ian J.
    Khan, Fary
    JOURNAL OF REHABILITATION MEDICINE, 2014, 46 (08) : 730 - 737